Our policy in the Medical Programs Department of the National Psoriasis Foundation (NPF) is to ensure balance, independence, objectivity, and scientific rigor in all our educational programs. Anyone presenting or participating in the planning of any NPF CME programs is expected to disclose to the Medical Programs Department any real or apparent affiliation(s) within the past 12 months that may have a direct bearing on the subject matter of the continuing medical education program. The intent of this policy is to ensure continuing medical education programs that are free of commercial interests.
The Dermatology-Rheumatology Trainee Psoriatic Disease Symposium faculty and planning committee have disclosed the following relationships with commercial interests:
Abby Van Voorhees, M.D.: Advisor-Amgen, AbbVie, Aqua, Celgene, Janssen, Leo, Novartis, Pfizer; Grants-Amgen, AbbVie; Consultant-Amgen; Speaker-Amgen, AbbVie, Janssen; Ex-spouse pension (portion)-Merck
Elaine Husni, M.D., MPH: Consultant-Celgene, Janssen, Genentech, Lilly, Novartis, AbbVie, Bristol Myers Squibb
Joseph Merola, M.D., MMSC: Advisory Board-Biogen IDEC, AbbVie, Eli Lilly, Novartis, Janssen; Consultant-Biogen IDEC; Investigator-Biogen IDEC, Pfizer; Licensed Outcome Measure-AbbVie; Speaker-AbbVie
Philip Mease, M.D.: Research Grant-AbbVie, Amgen, Bristol Myers Squibb, Celgene, Crescendo, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer, UCB; Consultant-AbbVie, Amgen, Bristol Myers Squibb, Celgene, Crescendo, CORRONA, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer, UCB; Speaker-AbbVie, Amgen, Bristol Myers Squibb, Celgene, Crescendo, Genentech, Janssen, Lilly, Pfizer, UCB
Emily Boyd and Leah North, National Psoriasis Foundation, have disclosed no relevant financial interests with any commercial interests.